These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27141155)

  • 1. Effective photodynamic therapy in drug-resistant prostate cancer cells utilizing a non-viral antitumor vector (a secondary publication).
    Yamauchi M; Honda N; Hazama H; Tachikawa S; Nakamura H; Kaneda Y; Awazu K
    Laser Ther; 2016 Mar; 25(1):55-62. PubMed ID: 27141155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy using a cytotoxic photosensitizer porphyrus envelope that targets the cell membrane.
    Inai M; Honda N; Hazama H; Akter S; Fuse S; Nakamura H; Nishikawa T; Kaneda Y; Awazu K
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():238-245. PubMed ID: 29079353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel photodynamic therapy for drug-resistant prostate cancer cells using porphyrus envelope as a novel photosensitizer.
    Yamauchi M; Honda N; Hazama H; Tachikawa S; Nakamura H; Kaneda Y; Awazu K
    Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):48-54. PubMed ID: 24629697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope.
    Sakai M; Fujimoto N; Ishii K; Nakamura H; Kaneda Y; Awazu K
    J Biomed Opt; 2012 Jul; 17(7):078002. PubMed ID: 22894526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy by lysosomal-targeted drug delivery using talaporfin sodium incorporated into inactivated virus particles.
    Akter S; Inai M; Saito S; Honda N; Hazama H; Nishikawa T; Kaneda Y; Awazu K
    Laser Ther; 2019 Dec; 28(4):245-256. PubMed ID: 32255916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope.
    Sakai M; Fujimoto N; Ishii K; Nakamura H; Kaneda Y; Awazu K
    J Biomed Opt; 2012 Jul; 17(7):077009. PubMed ID: 23066541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope.
    Sakai M; Fujimoto N; Ishii K; Nakamura H; Kaneda Y; Awazu K
    J Biomed Opt; 2012 Jul; 17(7):77009. PubMed ID: 23085849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient photodynamic therapy against drug-resistant prostate cancer using replication-deficient virus particles and talaporfin sodium.
    Akter S; Saito S; Inai M; Honda N; Hazama H; Nishikawa T; Kaneda Y; Awazu K
    Lasers Med Sci; 2021 Jun; 36(4):743-750. PubMed ID: 32592133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients.
    Fujita K; Nakai Y; Kawashima A; Ujike T; Nagahara A; Nakajima T; Inoue T; Lee CM; Uemura M; Miyagawa Y; Kaneda Y; Nonomura N
    Cancer Gene Ther; 2017 Jul; 24(7):277-281. PubMed ID: 28497777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles.
    Matsushima-Miyagi T; Hatano K; Nomura M; Li-Wen L; Nishikawa T; Saga K; Shimbo T; Kaneda Y
    Clin Cancer Res; 2012 Nov; 18(22):6271-83. PubMed ID: 23014529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle.
    Kawaguchi Y; Miyamoto Y; Inoue T; Kaneda Y
    Int J Cancer; 2009 May; 124(10):2478-87. PubMed ID: 19173282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
    Mukai H; Wada Y; Watanabe Y
    Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.
    Kaneda Y
    Expert Opin Drug Deliv; 2008 Feb; 5(2):221-33. PubMed ID: 18248320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the in vitro and in vivo effects of photodynamic therapy on prostate cancer by using new photosensitizers, protoporphyrin IX-polyamine derivatives.
    Fidanzi-Dugas C; Liagre B; Chemin G; Perraud A; Carrion C; Couquet CY; Granet R; Sol V; Léger DY
    Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1676-1690. PubMed ID: 28188858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of HVJ Envelope Vector and Its Application to Gene Therapy.
    Kaneda Y; Yamamoto S; Nakajima T
    Adv Genet; 2005; 53PA():307-332. PubMed ID: 16243069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of HVJ envelope vector and its application to gene therapy.
    Kaneda Y; Yamamoto S; Nakajima T
    Adv Genet; 2005; 53():307-32. PubMed ID: 16240999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope.
    Matsuda M; Yamamoto T; Matsumura A; Kaneda Y
    Gene Ther; 2009 Dec; 16(12):1465-76. PubMed ID: 19675593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New vector innovation for drug delivery: development of fusigenic non-viral particles.
    Kaneda Y
    Curr Drug Targets; 2003 Nov; 4(8):599-602. PubMed ID: 14577648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.